Sharp Aric R
Known title: CEO of Value Based CareCIK: 0001926602
Associated companies
Transaction History
| CLOV | ▼ Sell | Tax Withholding | 6,968 | $13K | 8/9/2024 | View on chart |
| CLOV | ▲ Buy | Grant | 456,265 | $0 | 6/30/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 137,108 | $169K | 6/30/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 6,798 | $6K | 5/9/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 8,266 | $8K | 2/9/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 10,515 | $9K | 11/9/2023 | View on chart |
| CLOV | ▲ Buy | Grant | 250,000 | $0 | 10/31/2023 | View on chart |
| CLOV | ▲ Buy | Grant | 1,368,750 | $0 | 9/7/2023 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 138,477 | $181K | 9/7/2023 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 7,037 | $10K | 8/9/2023 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 28,148 | $26K | 5/9/2023 | View on chart |
| CLOV | ▲ Buy | Grant | 370,967 | $0 | 5/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Clover Health Gains After Earning 5-Star CMS Rating
Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.
Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.